Publication | Closed Access
Topacio: Preliminary activity and safety in patients (pts) with platinum-resistant ovarian cancer (PROC) in a phase 1/2 study of niraparib in combination with pembrolizumab
20
Citations
0
References
2018
Year
Phase 1/2MedicineCancer ManagementGynecologyPreliminary ActivityImmune Checkpoint InhibitorPharmacotherapyPlatinum-resistant Ovarian CancerCancer TreatmentOncologyRadiation OncologyOvarian Cancer
No additional data available for this publication yet. Check back later!